Replies to post #296250 on Avid Bioservices Inc (CDMO)

[cheynew]

It reminds me of the Stason deal. Never to be heard of again. They are still in business.

http://www.stasonpharma.com/

[north40000]

" Astrazeneca Partnership is almost going on 2 years and absolutely NOTHING considered to be a Material Event has been done. There is also almost no mention of it anymore. My guess is it will slowly be just removed as to seem like it never happened."

I have wondered about that too. Could one explanation be that it is rather rare for 2 biologics[D + B] owned by 2 different companies, neither of which had approval for any indication, to be used in combination therapy? What FDA permissions, if any, would be necessary for that combination therapy to occur?

Now that Durvalumab has been approved by FDA for one indication this past Monday, is it reasonable to expect a status change?:

https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm555930.htm

If so, who will run the multiple tumor trial(s) and file the INDs?